Massive locally extensive prostate cancer

A massive, locally extensive adenocarcinoma of the prostate (2,246 ccm) presenting as constipation and a palpable abdominal mass, was treated with androgen deprivation resulting in a 94 percent reduction in tumor size, and relief of symptoms. Serum prostate-specific antigen was reduced from 4,029 to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Urology (Ridgewood, N.J.) N.J.), 1994-02, Vol.43 (2), p.242-243
Hauptverfasser:	Rozanski, Thomas A., Faerber, Gary J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - complications Adenocarcinoma - pathology Adenocarcinoma - therapy Aged Antineoplastic agents Biological and medical sciences Chemotherapy Combined Modality Therapy Constipation - etiology Flutamide - therapeutic use Humans Leuprolide - therapeutic use Male Medical sciences Pharmacology. Drug treatments Prostate - pathology Prostate-Specific Antigen - blood Prostatic Neoplasms - complications Prostatic Neoplasms - pathology Prostatic Neoplasms - therapy Radiotherapy Dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A massive, locally extensive adenocarcinoma of the prostate (2,246 ccm) presenting as constipation and a palpable abdominal mass, was treated with androgen deprivation resulting in a 94 percent reduction in tumor size, and relief of symptoms. Serum prostate-specific antigen was reduced from 4,029 to 0.4 ng/mL, after hormonal therapy was combined with radiation treatments for local disease control.
ISSN:	0090-4295 1527-9995
DOI:	10.1016/0090-4295(94)90054-X